Open for inclusion

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE 158)

Cancer type: Solide tumores

Phase: II

Principal Investigator: Jebsen Nina Loise

Country: NO

Keywords: Norway, Bergen, pembrolizumab

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02628067?term=KEYNOTE-158&rank=1